Catalent
CTLT
#1830
Rank
โ‚น1.074 T
Marketcap
โ‚น5,920
Share price
0.00%
Change (1 day)
23.92%
Change (1 year)
Catalent is an American pharmaceutical contract research and development company.

EPS for Catalent (CTLT)

EPS in 2024 (TTM): -โ‚น527.16

According to Catalent's latest financial reports the company's current EPS (TTM) is -โ‚น590.28. In 2023 the company made an earnings per share (EPS) of -โ‚น634.11 a decrease over its 2022 EPS that were of โ‚น211.68.

EPS history for Catalent from 2014 to 2024

Annual EPS

Year EPS Change
2024 (TTM)-โ‚น527.16-16.87%
2023-โ‚น634.11-399.56%
2022โ‚น211.68-30.58%
2021โ‚น304.9379.67%
2020โ‚น169.72114.12%
2019โ‚น79.26-15%
2018โ‚น93.2575.44%
2017โ‚น53.15-22.97%
2016โ‚น69.01-59.56%
2015โ‚น170.65282.05%
2014โ‚น44.67

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Supernus Pharmaceuticals
SUPN
-โ‚น63.41-89.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Jazz Pharmaceuticals
JAZZ
-โ‚น539.92-8.53%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Aerie Pharmaceuticals
AERI
-โ‚น69.94-88.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Intercept Pharmaceuticals
ICPT
-โ‚น138.01-76.62%๐Ÿ‡บ๐Ÿ‡ธ USA